PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
戊烯基糖苷——异头中心的转化
基本信息
- 批准号:2770957
- 负责人:
- 金额:$ 16.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-09-30 至 2000-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: The principal investigator states that the importance of the
project stems from the fact that of the three major families of biopolymers,
proteins, oligonucleotides and oligosaccharides, the last is the least well
understood because their isolation, structure-proof, and (above all) their
laboratory syntheses have been far more difficult and demanding than in the
case of the other two. He notes that however, great strides have been made
in the techniques of isolation and structure-proof which has made many of
these oligosaccharides available intact, and it is now clear that their
structures are usually of daunting complexity. He further indicates that
with the other two biopolymers, proteins and oligonucleotides, clarification
of their biological regulatory roles accelerated markedly with the advent of
synthetic methods that made them and/or their analogs, readily available for
structure activity correlations. It is noted that oligosaccharides usually
being the primary recognition agents on cell surfaces is now widely
appreciated, this step being a prelude to subsequent critical events such as
enzymolysis, cell penetration, etc and that thus bacteria, viruses, (many)
hormones, other cells, etc. must engage in this first step, and hence
undesirable events (such as bacterial infection) can conceivably be
prevented by the use of mimics to negate the recognition step. It is
further noted that on the other hand, beneficial interactions, as in the
case of hormones, can be facilitated so as to enhance recognition.
The principal investigator states that these visionary health-related
benefits rely ultimately on ready access to synthetic oligosaccharides, or
fragments and modifications thereof for biochemical evaluation and
structure-activity investigations. He notes that since their discovery in
his laboratory six years ago, n-pentenyl glycosides have proved to be
versatile synthetic precursors for several oligosaccharides and
glycoproteins and that with their credibility thereby established, he
envisages greatly extending their synthetic potential to address problems
associated with major health hazards. It is stated that examples of these
include the lipopolysaccharides associated with Leishmaniasis and the
endotoxin from lipid A and that exploratory studies aimed at developing
methodology for these targets is an important segment of the proposal.
描述:主要研究者指出,
该项目源于这样一个事实,即在生物聚合物的三大家族中,
蛋白质,寡核苷酸和寡糖,最后一种是最不好的
之所以被理解,是因为它们的隔离性、抗结构性以及(最重要的是)它们的
实验室合成比以前更加困难和要求更高
其他两个的情况。 他指出,然而,
在隔离和防结构技术方面,
这些寡糖可以完整地获得,现在很清楚,它们的
结构通常是令人生畏的复杂性。 他进一步指出,
与其他两种生物聚合物,蛋白质和寡核苷酸,澄清
它们的生物调节作用随着
制备它们和/或它们的类似物的合成方法,
结构活性相关性 应注意,寡糖通常
作为细胞表面的主要识别剂,
这一步骤是随后关键事件的前奏,
细菌,病毒,(许多)
激素,其他细胞等必须参与这第一步,因此,
可以想象,不良事件(例如细菌感染)可能会
通过使用模仿来否定识别步骤来防止。 是
还指出,另一方面,
激素的情况下,可以促进,以提高识别。
首席研究员指出,这些有远见的健康相关的
这些益处最终取决于合成低聚糖的易得性,或
用于生物化学评价的片段及其修饰,
结构活性研究。 他指出,自从他们在1999年被发现以来,
六年前,他的实验室已经证明,
多种寡糖的通用合成前体,
糖蛋白和他们的信誉,从而建立,他
设想大大扩展其合成潜力,以解决问题
与重大健康危害有关。 据指出,这些例子
包括与利什曼病相关的脂多糖,
脂质A中的内毒素以及旨在开发
实现这些目标的方法是建议的一个重要部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bertram Oliver Fraser-Reid其他文献
Bertram Oliver Fraser-Reid的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bertram Oliver Fraser-Reid', 18)}}的其他基金
Laboratory Syntheses of Mycobacterial tuberculosis LAM Prototypes
结核分枝杆菌 LAM 原型的实验室合成
- 批准号:
7626500 - 财政年份:2009
- 资助金额:
$ 16.65万 - 项目类别:
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
戊烯基糖苷——异头中心的转化
- 批准号:
2546017 - 财政年份:1996
- 资助金额:
$ 16.65万 - 项目类别:
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
戊烯基糖苷——异头中心的转化
- 批准号:
6093934 - 财政年份:1996
- 资助金额:
$ 16.65万 - 项目类别:
PENTENYL GLYCOSIDES--TRANSFORMATIONS AT ANOMERIC CENTER
戊烯基糖苷——异头中心的转化
- 批准号:
2180689 - 财政年份:1996
- 资助金额:
$ 16.65万 - 项目类别:
PENTENYL GLYCOSIDES IN TRANSFORMATIONS AT ANOMERIC CTR
异头 CTR 转化中的戊烯基糖苷
- 批准号:
3299122 - 财政年份:1990
- 资助金额:
$ 16.65万 - 项目类别:
相似海外基金
Bifunctional Catalysts for MHAT Hydrofunctionalization of Alkenes
用于烯烃 MHAT 加氢官能化的双功能催化剂
- 批准号:
2400341 - 财政年份:2024
- 资助金额:
$ 16.65万 - 项目类别:
Continuing Grant
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
- 批准号:
22KJ2498 - 财政年份:2023
- 资助金额:
$ 16.65万 - 项目类别:
Grant-in-Aid for JSPS Fellows
electrochemical dication pool: a new strategy to couple alkenes and abundant nucleophiles
电化学双阳离子池:偶联烯烃和丰富亲核试剂的新策略
- 批准号:
10635132 - 财政年份:2023
- 资助金额:
$ 16.65万 - 项目类别:
Development of Remote Bismetalation Reaction of Alkenes via Chain Walking
链式行走烯烃远程双金属化反应的进展
- 批准号:
22KJ2699 - 财政年份:2023
- 资助金额:
$ 16.65万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Connective Stereospecific Generation of Alkenes Continued
烯烃的连接立体定向生成(续)
- 批准号:
2247031 - 财政年份:2023
- 资助金额:
$ 16.65万 - 项目类别:
Standard Grant
Expanding the small molecule toolbox through novel applications of fluorinated alkenes
通过氟化烯烃的新颖应用扩展小分子工具箱
- 批准号:
10714822 - 财政年份:2023
- 资助金额:
$ 16.65万 - 项目类别:
Methods for Enantioselective Spirocycle Synthesis and Radical Hydroamination of Trisubstituted Alkenes
三取代烯烃的对映选择性螺环合成和自由基氢胺化方法
- 批准号:
10785901 - 财政年份:2023
- 资助金额:
$ 16.65万 - 项目类别:
Ruthenium-catalyzed hydrophosphination of alkenes
钌催化的烯烃氢膦酸化
- 批准号:
575021-2022 - 财政年份:2022
- 资助金额:
$ 16.65万 - 项目类别:
University Undergraduate Student Research Awards
New Catalytic Transformations for the Synthesis of Alkenes and Organoboron Compounds
烯烃和有机硼化合物合成的新催化转化
- 批准号:
2102231 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Continuing Grant
Development of Enantioselective Carboalumination of Alkenes and Alkynes Catalyzed by Rare-Erath Metal Catalysts
稀土金属催化剂催化烯烃和炔烃对映选择性碳铝化反应的研究进展
- 批准号:
21F21334 - 财政年份:2021
- 资助金额:
$ 16.65万 - 项目类别:
Grant-in-Aid for JSPS Fellows